Composites refer to the material as a combination of two materials with different physical and chemical properties that have excellent strength-to-weight ratios and durability, are stronger than those individual materials by themselves, are corrosion resistant, durable, and have a lighter weight than most metals. The components of the composites market are carbon fiber and glass fiber. Carbon fibre is a lightweight but very strong material. Carbon fibre is more firm than steel and five times stronger than it. The manufacturing process for these composites includes the layup process; filament winding process; injection moulding process; pultrusion process; compression moulding process; resin transfer moulding process; and others. They are divided based on resin type into thermoset composites and thermoplastic composites. Composites are used by various end users, such as aerospace and defense, wind energy, automotive and transportation, construction and infrastructure, marine, pipe and tank, electrical and electronics, and others. The composites market research report is one of a series of new reports from The Business Research Company that provides composites market statistics, including composites market industry global market size, regional shares, competitors with composites market share, detailed composites market segments, market trends and opportunities, and any further data you may need to thrive in the composites market industry. This composites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global composites market size grew from $88.9 billion in 2022 to $98.91 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The composites market size is expected to grow to $154.39 billion in 2027 at a CAGR of 11.8%. Growth in the automotive and aerospace sectors is expected to propel the growth of the composites market. In the automotive and aerospace industries, composites are used to provide improved performance, corrosion resistance, and fuel savings. According to the International Trade Administration, in 2020, aircraft manufacturing and repair services in Australia generated revenue in excess of $2.0 billion. Also, according to IBEF, Indian automobile exports stood at 1,419,430 units from April 2021 to June 2021 as compared to 436,500 units from April 2020 to June 2020. Therefore, the growth in the automotive and aerospace sectors is driving the growth of the composites market. The composite market consists of the sales of composite materials by entities (organizations, partnerships, and sole proprietors) that refer to the material as a combination of two materials with different physical and chemical properties that have excellent strength-to-weight ratios and durability and are stronger than those individual materials by themselves. Some of the applications for these products include aerospace, automotive, and high-tech electronics. They are corrosion resistant, durable, and have a lighter weight than most metals. This sector is expected to propel the growth of the composites market. In the automotive and aerospace industries, composites are used to provide improved performance, corrosion resistance, and fuel savings. According to the International Trade Administration, in 2020, aircraft manufacturing and repair services in Australia generated revenue in excess of $2.0 billion. Also, according to IBEF, Indian automobile exports stood at 1,419,430 units from April 2021 to June 2021 as compared to 436,500 units from April 2020 to June 2020. Therefore, the growth in the automotive and aerospace sectors is driving the growth of the composites market. Technological advancements are a key trend gaining popularity in the composites market. Technological advancements to reduce composite structural mass are a type of knowledge discovery that advances technology.For instance, in June 2021, Hexcel Corporation, a US-based manufacturer of reinforcement products, composite materials, and engineered products, successfully launched the first successful maiden flight of a lightweight camera drone, using Hexcel HexPly carbon fibre prepregs. The composite drone was created by a group of students from the University of Applied Sciences Upper Austria in Wels using composite materials provided by Hexcel. The material allowed the team to lower the composite structural mass by 42% when compared to similar drones. In January 2022, JGC Holdings Corporation, a Japan-based engineering company, acquired ceramic composite products from Showa Denko Materials Co., Ltd. for an undisclosed amount. Through this acquisition, this current business is complemented by the one acquired from SDMC to strengthen its position in automotive, semiconductor, and industrial equipment applications. It consists of high-density silicon carbide ceramics, alumina ceramics, and zirconia-toughened alumina ceramics, as these goods are employed in coolant pump seals for automobile engines and require precise positioning. Showa Denko Materials Co., Ltd. is a Japan-based material technology company pioneering in the manufacturing and commercialization of chemical products for various industries. Major players in the composites market are DuPont, Gurit, Henkel Corporation, Hexcel Corporation, Huntsman International LLC., Kineco Limited, Koninklijke Ten Cate BV, Mitsubishi Chemical Holdings Corporation, Nippon Electrical Glass Co. Ltd. (Japan), Owens Corning, SGL Group, Teijin Limited, Toray Industries, Veplas Group, Weyerhaeuser Company, BASF SE, and BGF Industries Inc., Asia-Pacific was the largest region in the composites market in 2022 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the composites market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the composites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The composites market consists of sales of natural fiber, aramid fiber, ceramic fiber, and metal fiber. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global composites market is segmented - 1) By Product: Carbon Fiber, Glass Fiber 2) By Manufacturing Process: Layup Process, Filament Winding Process, Injection Molding Process, Pultrusion Process, Compression Molding Process, Resin Transfer Molding Process, Other Processes 3) By Resin Type: Thermoset Composites, Thermoplastic Composites 4) By End-Use Industry: Aerospace and defense, Wind Energy, Automotive and Transportation, Construction & Infrastructure, Marine, Pipe and Tank, Electrical and Electronics, Other End-Users

Ceramic matrix composites refer to a unique kind of composite material where the matrix and reinforcement (refractory fibers) are both made of ceramic, with the material consisting of a ceramic matrix that is mixed with a ceramic dispersed phase to provide mechanical strength and improve the toughness of conventional ceramics. The main types of ceramic matrix composites are oxide/oxide, carbon/silicon carbide, carbon/carbon, and silicon carbide/silicon carbide. The main categories of ceramic matrix composites are short fiber, long continuous fiber, and whiskers. The production methods used to make ceramic matrix composites are powder dispersion, reactive melt infiltration, polymer impregnation and pyrolysis, gaseous infiltration, chemical vapour infiltration, and sol-gel. Ceramic matrix composites are used in industries such as aerospace and defense, transportation, energy, electrical and electronic, and medical. The ceramic matrix composites research report is one of a series of new reports from The Business Research Company that provides Ceramic matrix composites statistics, including Ceramic matrix composites industry global market size, regional shares, competitors with Ceramic matrix share, detailed Ceramic matrix composites segments, market trends and opportunities, and any further data you may need to thrive in the Ceramic matrix industry. This Ceramic matrix composites research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global ceramic matrix composites market size grew from $12.41 billion in 2022 to $13.64 billion in 2023 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ceramic matrix composites market size is expected to grow to $20.24 billion in 2027 at a CAGR of 10.4%. The high demand for lightweight automobiles across the globe is contributing to the growth of the ceramic matrix composites market. The increased demand for lightweight electric vehicles has turned automakers' focus to lightweight composite materials as a substitute for heavier steel and iron in vehicles. For instance, according to McKinsey, the automotive industry is expected to increase the use of lightweight materials by 30 to 70% by 2030. So, high demand for lightweight automobiles will drive the ceramic matrix composites market. Strategic collaborations and partnerships are a key trend gaining popularity in the ceramic matrix composites market. Strategic collaboration and partnerships between key market players creating innovative technologies to develop innovative products and sustain the position in the ceramic matrix composites market. For instance, in April 2020, United Technologies Corporation, a US-based conglomerate company, merged with Raytheon Company, a U.S.-based defence contractor and industrial corporation company, for an undisclosed amount. In January 2022, JGC Holdings Corporation, a Japan-based engineering company, acquired ceramic composite products from Showa Denko Materials Co., Ltd. for an undisclosed amount. Through this acquisition, this current business is complemented by the one acquired from SDMC to strengthen its position in automotive, semiconductor, and industrial equipment applications. It consists of high-density silicon carbide ceramics, alumina ceramics, and zirconia-toughened alumina ceramics, as these goods are employed in coolant pump seals for automobile engines and require precise positioning. Showa Denko Materials Co., Ltd. is a Japan-based material technology company pioneering in the manufacturing and commercialization of chemical products for various industries. Major players in the ceramic matrix composites market are General Electric Company, Rolls-Royce, SGL Carbon, Axiom Materials Inc., United Technologies, 3M Company, COI Ceramics, Lancer Systems, CoorsTek, Applied Thin Films, Ultramet, CFC Carbon Co. Ltd., UBE Industries Ltd., Kyocera Corporation, Speciality Materials Inc., and Safran. North America will be the largest region in the ceramic matrix composites market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ceramic matrix composites market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Ceramic Matrix Composites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The ceramic matrix composites market consists of sales of alumina, mulite, polymer matrix composites, ceramic matrix composites, and metal matrix composites.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It doesnot include revenues from resales either further along the supply chain or as part of other products. The global ceramic matrix composites market is segmented - 1) By Type: Oxide/Oxide, Carbon/Silicon Carbide, Carbon/Carbon, Silicon Carbide/Silicon Carbide 2) By Category: Short Fiber, Long Continous Fiber, Whiskers 3) By Production Method: Powder Dispersion, Reactive Melt Infiltration, Polymer Impregnation and Pyrolysis, Gaseous Infiltration, Chemical Vapor Infiltration, Sol-Gel 4) By End-Use Industry: Aerospace and Defense, Transportation, Energy, Electrical and Electronic, Medical

Bioadhesives are natural polymers that are derived from bio-based raw materials to bond two surfaces together. It refers to the phenomenon in which synthetic and natural materials adhere to biological surfaces. The bioadhesives are used as adhesive materials for artificial applications. Bioadhesives are cheaper and easier to manufacture, and they have the potential to replace synthetic adhesives. The main types of bioadhesives are plant-based and animal-based. Plant-based bioadhesives are the adhesives that are produced from the plant and are used in properties such as matrix formation and environment. These are produced by various methods such as direct chemical synthesis, bacteria and yeast fermentation, and natural organism farming, and are used in various industries such as packaging industries, paper and pulp industries, construction industries, personal care industries, healthcare industries, and others. The bioadhesives market research report is one of a series of new reports from The Business Research Company that provides bioadhesives market statistics, including bioadhesives industry global market size, regional shares, competitors with a bioadhesives market share, detailed bioadhesives market segments, market trends and opportunities, and any further data you may need to thrive in the bioadhesives industry. This bioadhesives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global bioadhesives market size grew from $4.52 billion in 2022 to $5.07 billion in 2023, at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bioadhesives market size is expected to grow to $7.47 billion in 2027 at a CAGR of 10.2%. Governmental regulations and policies to control environmental pollution are significantly contributing to the growth of the bioadhesives market. The governments are more concerned about the adverse effects of pollution on public health and the environment, so they have implemented regulations to control air pollution, and this has increased the demand for the use of bio-based materials such as bioadhesives. For instance, in March 2022, the United Kingdom government set additional goals to be incorporated into the Environment Act 2021, including a legally obligatory goal to reduce fine particulate matter (PM2.5) levels to 10 micrograms per cubic metre (g/m3) by 2040. The new targets included a 35% decrease in population exposure to PM2.5 by 2040 compared to levels in 2018, and they covered water, air quality, and biodiversity. Therefore, governmental regulations and policies to control environmental pollution are expected to propel the growth of the bioadhesives market going forward. Strategic partnerships and collaborations have emerged as the key trends gaining popularity in the bioadhesives market. Key players operating in the bioadhesives sector are focused on partnerships and collaborations to reinforce their positions. For instance, in March 2021, Technol, a UK-based company operating in clean technology, partnered with Beardow Adams, a UK-based company that manufactures bioadhesives. With this collaboration, they intended to offer packaging solutions for sustainable packaging to support a sustainable future. Moreover, in January 2021, Bemis Associates, a US-based manufacturer of thermoplastic films, tapes, and adhesives, partnered with DuPont Tate & Lyle Bio Products partnered to launch the world's first SewFree product made from renewable materials. DuPont Tate & Lyle Bio Products is a US-based company that offers bioadhesives. In August 2021, Arkema, a France-based chemicals company, acquired Ashland’s performance adhesives business for an undisclosed amount. With this acquisition, the group aimed to become a pure specialty materials player by 2024, with an emphasis on sustainable and high-performance solutions. Ashland is a US-based chemical company that manufactures bioadhesives. Major players in the bioadhesives market are Arkema S.A., Beardow Adams, Ashland Global Specialty Chemicals Inc., EcoSynthetix Inc., Bioadhesive Alliance Inc., DuPont, Tate & Lyle PLC, Cryolife Inc., Yparex B.V., Camurus, Follmann GmbH & Co. KG, Kollodis BioSciences Inc., and Bemis Associates Inc. Europe was the largest region in the bioadhesives market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioadhesives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the bioadhesives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The bioadhesives market consists of sales of bioadhesives for use in clinical applications such as tissue sealants and hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global bioadhesives market is segmented - 1) By Type: Plant-Based, Animal-Based 2) By Production Methods: Direct Chemical Synthesis, Bacteria and Yeast Fermentation, and Natural Organism Farming 3) By Industry: Packaging Industries, Paper and Pulp Industries, Construction Industry, Personal Care, Healthcare, Other Industries

The biopesticides include certain types of pesticides derived from natural materials such as animals, plants, bacteria, and certain minerals. Biopesticides are biological, natural substances that manage a wide range of agricultural pests found in forests, gardens, and farmlands. This includes plant-incorporated protectants, biochemical pesticides, and microbial pesticides. The main types of biopesticides are bioinsecticides, biofungicides, bionematicides, bioherbicides, and others. Bio nematodes are biopesticides used to protect crops from nematode infestation. The bio nematicides are environmentally friendly and have no negative effects on soil fertility or crop quality. The various sources of biopesticides include microbials, biochemicals, and beneficial insects and are available in liquid and dry formulations. Biopesticides are applied for different modes of application such as seed treatment, soil treatment, foliar spray, and others. The biopesticides research report is one of a series of new reports from The Business Research Company that provides biopesticides statistics, including biopesticides industry global market size, regional shares, competitors with biopesticides share, detailed biopesticides segments, market trends and opportunities, and any further data you may need to thrive in the biopesticides industry. This biopesticides research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biopesticides market size grew from $5.11 billion in 2022 to $6.13 billion in 2023 at a compound annual growth rate (CAGR) of 19.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The biopesticides market size is expected to grow to $11.27 billion in 2027 at a CAGR of 16.4%. The rising demand for organic food is expected to propel the growth of the biopesticides market going forward. During the COVID-19, the demand for organic food has increased as buyers perceived it as healthier and good for immunity. Biopesticides are composed of toxins found in living organisms that are harmful to pests that attack plants but have no effect on the plant itself, therefore reducing soil pollution and erosion. As a result, biopesticides are used in organic crop production. For instance, according to the Healthline report, U.S. consumers spent nearly $56 billion on organic produce in the year 2020. In addition, according to the US Organic Trade Association, organic product sales reached 12.4% in 2020, surpassing $60 billion for the first time and more than twice the previous year's growth. Therefore, the rising demand for organic food will drive the growth of the biopesticides market. Technological advancement has emerged as a key trend in the biopesticides market. Biopesticides manufacturers are developing new bacterial strains using new technologies for biological control of pests and plant diseases. For instance, in February 2021, Ballagro Agro Technology Ltd., a Brazil-based agricultural company launched biopesticide Acera based on Embrapa technology. Acera is a biopesticide formed by mixing two isolates of Bacillus thuringiensis (BT) bacteria. Bacillus thuringiensis (BT) is a bacterial species that produce proteins with poisonous effects for insects but not for humans or other animals. It is not harmful to the environment, unlike chemical pesticides. The substance must be sprayed on the leaves, and the caterpillars are influenced by the action of such proteins when they eat them. The product will benefit crops such as soybeans, corn, and cotton in particular. In October 2020, Syngenta Group, a Switzerland-based company that provides agricultural science and technology acquired Valagro for an undisclosed amount. This acquisition strengthens Syngenta Group's goal of offering farmers more complimentary product and technology options, which reinforces the company's commitment to making agriculture more resilient and sustainable. Valagro is an Italy-based company that is specialized in the manufacturing and sale of biostimulants and specialty nutrients. Major players in the biopesticides market are BASF SE, Syngenta AG, Bayer AG, Marrone Bio Innovation, Novozymes A/S, Koppert Biological Systems, FMC Corporation, International Panaacea Ltd., Som Phytopharma India Ltd., BioWorks Inc., Valent Biosciences LLC, Andermatt Biocontrol AG, Isagro S.p.A, Certis US L.L.C, DowDuPont, The Stockton (STK) Group, InVivo Group, Vegalab S.A, Biobest Group NV, STK Bio-ag, Bionema, Corteva Agriscience, Sumitomo Chemical Co. Ltd., Omnia Holdings Limited, Amit Biotech, Agbiochem Inc., Agbitech Pty Ltd., Arbico Organics, Arysta Lifescience, and Stoller. North America was the largest region in the biopesticides market in 2022. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in the biopesticides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biopesticides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The biopesticides market consists of sales of biopesticides extracted from various sources such as plant extracts and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biopesticides market is segmented - 1) By Type: Bioinsecticides, Biofungicides, Bionematicides, Bioherbicides, Other Types 2) By Source: Microbials, Biochemicals, Beneficial insects 3) By Formulation: Liquid Formulation, Dry Formulation 4)By Mode Of Application: Seed TreATMent, Soil TreATMent, Foliar Spray, Other Mode Of Applications

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials. The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various route of administration includes oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global biologics market is expected to grow from $382.04 billion in 2022 to $416.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The biologics market is expected to reach $599.62 billion in 2027 at a CAGR of 9.5%. Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early. The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth. The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA’s Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products. Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL. North America was the largest region in the biologics market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biologics market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The biologics market consists of sales of Tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biologics market is segmented - 1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribtuion Channels 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines

Aerospace composites refer to superior materials used to make effective aircraft components and enhance the performance of commercial and military aircraft. Aerospace composites have superior physical properties and exceptional strength and stiffness-to-density ratios. Composites can be manufactured in different shapes, which reduces corrosion resistance and material wastage. The main types of aerospace composites include carbon fiber composites, ceramic fiber composites, glass fiber composites, and others. Carbon composites are a broad class of materials in which carbon structures are spread throughout a material. They offer strength and stiffness while keeping them relatively lightweight. Ceramic composites offer excellent temperature stability, damage-tolerant fracture behavior, low density, good corrosion, high hardness, and wear resistance. Glass fiber composites offer flexibility, high strength, stiffness, and durability. Aerospace composites are mainly used in commercial aircraft, business and general aviation, civil helicopters, military aircraft, and others. The two major types of applications of aerospace composites are interior and exterior. Aerospace composites are manufactured through AFP/ATL, the lay-up process, resin transfer molding process, filament winding process, and other processes. Resins used for aerospace composites include benzoxazine, cyanate ester, bismalimide, ceramic and metal matrix, thermosetting resins, polyester, and others. The aerospace composites market research report is one of a series of new reports from The Business Research Company that provides aerospace composites market statistics, including aerospace composites industry global market size, regional shares, competitors with an aerospace composites market share, detailed aerospace composites market segments, market trends and opportunities, and any further data you may need to thrive in the aerospace composites industry. This aerospace composites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global aerospace composites market size grew from $26.25 billion in 2022 to $29.95 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The aerospace composites market size is expected to grow to $51.83 billion in 2027 at a CAGR of 14.7%. The increase in demand for high-strength and lightweight composite materials is expected to drive the aerospace composites market. Energy efficiency can be increased, and fuel consumption can be reduced by using lightweight materials and thereby reducing the mass of the aircraft, as a lower mass requires less lift force and thrust during flight. Lightweight design helps in reducing the carbon footprint, higher structural strength and stiffness, flight performance improvements such as better acceleration, and better safety performance. For instance, according to the report ‘2020 State of the Industry Report’ by the Composites Manufacturing Magazine, a US-based magazine related to composite manufacturing, the US composite end products market is expected to touch $33.4 billion by 2025 at a growth rate of 3.8% with glass fiber-based composites dominating the market. Therefore, increasing use of lightweight materials positively impacts the aerospace composites market's growth. Companies in the aerospace composites market are focusing on technological advancement to accelerate and develop composite material and process technologies for the next generation of energy-efficient aircraft and future mobility. Airlines are trying to replace outdated aircraft with technologically advanced and modern aircraft. These new aircraft are equipped with increased payload capacities and cost-efficiency. As a result of this, there is widespread adoption of aerospace composites across the globe. For example, in March 2021, GKN Aerospace, a UK-based company involved in the automotive and aerospace components business, launched a consortium called ASCEND (aerospace and automotive supply chain enabled development). With this launch, the UK has become a technology leader in future lightweight structures. It also helps to reduce carbon emissions and energy consumption in the aerospace industry. In September 2020, private investment firm Architect Equity acquired the Aerospace Composites Division of AAR Corp., a company engaged in providing aerospace and defense aftermarket solutions, for an undisclosed amount. Through this acquisition, Architect is expected to design and manufacture complex aerospace products with AAR Corp. and pursue new opportunities in the composites manufacturing space. The aerospace composites division will do business as Aeromatrix Composites. Aeromatrix is a US-based company that designs, fabricates, and assembles composite products and solutions for customers in the commercial aerospace and defense industries. Major players in the aerospace composites market are Solvay, Toray Industries Inc., Mitsubishi Chemical Holdings, Hexcel Corporation, Teijin Limited, SGL Group, Spirit AeroSystems, Materion Corporation, Owens Corning, Spirit AeroSystems Inc., LEE Aerospace Inc., Gurit Holding AG, General Electric Corporation, Rolls-Royce Motor Cars Ltd., Kineco-Kaman Composites, and Nippon Graphite Fiber Corporation. North America was the largest region in the aerospace composites market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aerospace composites market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the aerospace composites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The aerospace composites market consists of sales of aramid-reinforced epoxy, and boron-reinforced aerospace composites.  Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global aerospace composites market is segmented - 1) By Fiber Type: Carbon Fiber Composites, Ceramic Fiber Composites, Glass Fiber Composites, Others 2) By Aircraft Type: Commercial Aircraft, Business & General Aviation, Civil Helicopter, Military Aircraft, Others 3) By Manufacturing Process: AFP/ATL, Lay-Up Process, Resin Transfer Moulding Process, Filament Winding Process, Others 4) By Resin Type: Benzoxazine, Cyanate Ester, Bismalimide, Ceramic and Metal Matrix, Thermosetting Resins, Polyester, Others 5) By Application: Interior, Exterior

Biohacking, also known as human augmentation or human enhancement, is a type of do-it-yourself biology that aims to improve ability, fitness, and wellbeing through intentional interventions. The main product types of the biohacking market are wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps, and other products. Wearables refer to the category of electronic devices that can be worn as accessories. These devices help in body tracking and checking the condition of the body. The different components include solutions and services that are used in several applications, such as synthetic biology, genetic engineering, forensic science, diagnosis and treatment, and drug testing. It is employed in pharmaceutical and biotechnology companies, hospitals and clinics, forensic laboratories, research and academic institutes, and other end users. The biohacking report is one of a series of new reports from The Business Research Company that provides biohacking statistics, including biohacking industry global market size, regional shares, competitors with a biohacking share, detailed biohacking segments, market trends and opportunities, and any further data you may need to thrive in the biohacking industry. This biohacking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biohacking market size grew from $23.34 billion in 2022 to $28.87 billion in 2023 at a compound annual growth rate (CAGR) of 23.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biohacking market size is expected to grow to $65.95 billion in 2027 at a CAGR of 22.9%. The rising prevalence of chronic diseases is expected to propel the growth of the biohacking market going forward. Chronic diseases are conditions or illnesses that often last for three months or longer and have the potential to get worse over time. Biohacking methods such as improving the nutrition of the body, intermittent fasting, hydrogen inhalation therapy, and others can help to fight cancer and other chronic diseases. For instance, according to the World Health Organization, a US-based specialized agency responsible for international public health, chronic disease prevalence has risen by 57% in the year 2020. Also, 19.3 million new cancer cases were registered, and almost 10.0 million cancer deaths occurred in 2020. Therefore, the rising prevalence of chronic diseases is driving the growth of the biohacking market. Increasing adoption of biohacking practices by consumers is expected to propel the growth of the biohacking market going forward. Biohacking practices such as meditation and intermittent fasting help with increasing mental focus, provide increased drive and energy, and help the body work efficiently, making it easier to fight illness. For instance, according to WebWire, a US-based online news channel, the size of the meditation market in the US is predicted to reach $2.08 billion by 2022. Therefore, the increasing adoption of biohacking practices by consumers is driving the growth of the biohacking market. Product advancement is a key trend gaining popularity in the biohacking market. Major companies operating in the biohacking sector are focused on new product advancements to strengthen their position in the market. For instance, in January 2022, Velovita, a US-based biohacking solutions provider, introduced Zlem, a dietary supplement bio-hacking formula for quality sound sleep and weight management. Zlem is a potent supplement with more than 20 ingredients that can help users sleep better and burn fat that has accumulated in the body while resting at night. This product also helps the body get rid of impurities and gives users a balanced, healthy state of mind every morning. Major players in the biohacking market are Thync Global Inc., Fitbit Inc., OsteoStrong, HVMN Inc., Thriveport LLC, Apple Inc., Kaatsu Global, TrackMyStack, Interaxon Inc., SynBioBeta LLC, Elysium Health, InteraXon Inc., Behavioral Tech, Synbiota, and Primal Life Sciences. North America was the largest region in the biohacking market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the biohacking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biohacking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The biohacking market consists of sales of TrueDark glasses, sleep systems, skin care systems, and supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biohacking market is segmented - 1) By Product: Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps, Other Products 2) By Component: Solution, Services 3) By Application: Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis and Treatment, Drug Testing 4) By End-User: Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Forensic Laboratories, Research and Academic Institutes, Other End Users

Biotechnology services refer to the services that modify living microorganisms to provide biotechnology products on a contract or custom basis to medical, pharmaceutical, and scientific laboratories. They provide breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes. The main types of biotechnology services are prevention and disease control; public engagement activities; health education and research; food biotechnology services; donor recruitment; tissue collection; cell processing and isolation; and research and development. Food biotechnology services encompass a diverse variety of technologies used in crops, livestock, forestry, fisheries and aquaculture, and agro-industry. They are used for a variety of purposes, including genetic improvement of plants and animals to increase yields or efficiency, characterization and conservation of genetic resources for food and agriculture, plant and animal disease diagnosis, vaccine development, and fermented food production. The various applications include pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors and are used by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS). The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biotechnology services market size will grow from $146.85 billion in 2022 to $163.71 billion in 2023 at a compound annual growth rate (CAGR) of 11.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biotechnology services market size is expected to grow to $241.17 billion in 2027 at a CAGR of 10.2%. The increasing pervasiveness of conditions like hepatitis B, diabetes, and cancer is driving research in biotechnology. Biotechnology uses research tools from biology and chemistry to study the genetic material of bacteria and viruses to check the disease-producing agents. Oncology research is most prominent among biopharma companies. Stem cell treatment using a monoclonal antibody for therapy and genome sequencing is progressing in medical applications. According to the Indian Economic Survey 2021, the Indian biotechnology business is predicted to grow to US$ 150 billion by 2025. Global R&D spending by the world's largest publicly traded biotech companies increased by 13.7 percent each year, from $4.8 billion in 2001 to $55.0 billion in 2020. Therefore, the rising pervasiveness of diseases and huge expenses on R&D are predicted to contribute to the growth of the biotechnology services market. The risk related to genetic data is anticipated to limit the growth of the biotechnology services market. The biotechnological approach of transferring specially created genes for modification in characteristics to create genetically modified organisms (GMOs) has always been considered a threat to human and environmental health. According to the report of the World Conservation Union, there are numerous environmental risks likely to occur due to the use of GMOs, which include interbreeding, antibiotic resistance, impact on the ecosystem, creation of new or worse viruses, competition with natural species, unpredictable and unintended effects, and ethical concerns. The World Health Organization (WHO) has also set guidelines for manufacturers of GMO food. The National Bioengineered Food Disclosure Standard has been implemented in the USA since January 2020, making it mandatory to label all foods containing genetically engineered items as "bioengineered". Thus, the risk associated with genetically modified items is negatively impacting the growth of the biotechnology services market. Collaborations and partnerships between industry players are a growing trend in the field of biotech services. In January 2021, Novartis, a Switzerland-based pharmaceutical company collaborated with Alnylam, a US-based biopharmaceutical company for exploration in the application of the latter’s siRNA technology and the development of targeted therapy for the restoration of liver function. As part of the exclusive three-year research collaboration, Alnylam will develop and test potential siRNAs using Novartis' target-specific assays. Novartis will conduct further development and clinical research once a lead candidate has been identified. In October 2021, Amgen, a US-based biopharmaceutical company, acquired all outstanding shares of Teneobio for a deal amount of $2.5 billion. Amgen acquired Teneobio's bispecific and multispecific antibody technologies as part of the acquisition. These solutions complement the company's existing antibody expertise and BiTE platform. This will aid in the discovery and advancement of novel molecules for the treatment of a wide range of illnesses in Amgen's major treatment areas. TeneoBio is a US-based biotechnology business that specialises in the production of human heavy chain antibodies. Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron. Asia-Pacific was the largest region in the biotechnology services market in 2022. North America was the second largest region in the global biotechnology services market. The regions covered in the global biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the biotechnology services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The global biotechnology services market is segmented - 1) By Service: Prevention and Disease Control, Public Engagement Activities, Health Education and Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Research and Development 2) By Industry: Clinical Research Organizations (CROs), Contract Manufacturers Organizations(CMOs), Contract Research and Manufacturing Services (CRAMS) 3) By Area of Application: Pharmaceutical, Biotechnological, Academic, Clinical Trial, Healthcare Sectors